Role of iodine in antioxidant defence in thyroid and breast disease

BioFactors

Volumn 19, Issue 3-4, 2003, Pages 121-130

  Smyth, Peter P A ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Antioxidant; Breast; Iodine; Thyroid; Thyroid antibodies

Indexed keywords

ANTIOXIDANT; FREE RADICAL; GLUTATHIONE PEROXIDASE; IODIDE; IODINE; LIOTHYRONINE; PROPYLTHIOURACIL; SELENIUM; SELENOMETHIONINE; THIAMAZOLE; THYROGLOBULIN; THYROID HORMONE; THYROID PEROXIDASE ANTIBODY; THYROXINE;

ANTIOXIDANT ACTIVITY; APOPTOSIS; AUTOIMMUNITY; BREAST CANCER; BREAST DISEASE; CARCINOGENESIS; CELL DEATH; CELL PROTECTION; CONFERENCE PAPER; CYTOTOXICITY; ENZYME ACTIVITY; GOITER; HUMAN; INVOLUTION; IODINATION; IODINE DEFICIENCY; PRIORITY JOURNAL; PROGNOSIS; RADIOIMMUNOASSAY; SEAWEED; SELENIUM DEFICIENCY; THYROID CELL; THYROID DISEASE;

ALGAE;

EID: 0842264912     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520190304     Document Type: Conference Paper

References (87)

1. M.B. Curtois, Decouvert d'une substance nouvelle dans le varech, Ann. de Chemie 88 (1813), 304.
2. E. Baumann, Ueber das normale Verkommen von Jod im Thierkorper, Ztschr Physiol. Chemie 21 (1895), 319.
3. C.R. Harrington and G. Barger, Chemistry of thyroxine 111. Constitution and synthesis of thyroxine, Biochem J 21 (1927), 169.
4. E.F. Elstner, R. Adamczyk, R. Kromer and A. Furch, The uptake of potassium iodide and its effects as an antioxidant in isolated rabbit eyes, Ophthalmologica 191 (1985), 122-126.
5. G. Rieger, R. Winkler, W. Buchberger and M. Moser, Iodine distribution in a porcine eye model following iontophoresis, Ophthalmologica 209(2) (1995), 84-7.
6. J.F. Denef, M.C. Many and M.F. van den Hove, Iodine-induced thyroid inhibition and cell necrosis: two consequences of the same free-radical mediated mechanism? Molecular and Cell Endo 121 (1996), 101-103.
7. R. Winkler and M. Klieber, Important results of about 45 years balneo-medical research in Bad Hall, WienMedWorchenschrSupp 148 (1998), 3-11.
8. S. Venturi, F.M. Donati, M. Venturi, A. Venturi, L. Grossi and A. Guidi, Role of Iodine in Evolution and Carcinogenesis of Thyroid, Breast and Stomach, Advances in Clinical Pathology 4 (2000), 11-17.
9. A. Taurog, M.L. Lothrop and R.W. Estabrook, Improvements in the isolation procedure for thyroid peroxidase: Nature of the heme prosthetic group, Arch Biochem Biophys 139 (1970), 221.
10. A. Taurog, Hormone synthesis: thyroid iodine metabolism, in: 'Werner and Ingbar's The Thyroid, L. Braverman and R.D. Utiger, eds, Philadelphia: Lippincott Co, 1996, pp. 47-81.
11. L.J. Degroot and H. Niepomniszcze, Biosynthesis of thyroid hormone: Basic and Clinical Aspects, Metabolism 26 (1977), 665-718.
12. J.E. Dumont, F. Lamy, P. Roger and C. Mainhault, Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors, Physiol Reviews 72 (1992), 667-697.
13. K. Yamamoto and L.J. DeGroot, Participation of NADPH-cytochrome c reductase in thyroid hormone biosynthesis, Endocrinology 96 (1975), 1022.
14. M. Birringer, S. Pilawa and L. Flohe, Trends in selenium biochemistry, Nat Prod Rep 6 (2002), 693-718.
15. P.P. Roger, D. Christophe, J.E. Dumont and I. Pirson, Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system, Eur J Endocrinol 137 (1997), 579-598.
16. L.D. Kohn, K. Suzuki, M. Nakazato, I. Royaux and E.D. Green, Effects of thyroglobulin and pendrin on iodide flux through the thyrocyte, Trends Endocrinol Metab 12 (2001), 10-16.
17. 2-generating system modulates protein iodination and the activity of the pentose phosphate pathway in dog thyroid, Endocrinology 128 (1991), 779-785.
18. ++ and reduced nicotinamide adenine dinucleotide phosphate-dependent hydrogen peroxide generating system is induced by thyrotropin in porcine thyroid cells, Endocrinology 137(3) (March 1996), 1007-1012.
19. X. De Deken, D. Wang, J.E. Dumont and F. Miot, Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system, Exp Cell Res 273 (2002), 187-196.
20. B. Corvilain, B. Contempre, A.O. Longombe, P. Goyens, C. Gervy-Decoster, F. Lamy, J.B. Vanderpas and J.E. Dumont, Selenium and the thyroid: how the relationship was established, Am J Clin Nutr 57(2 Suppl) (Feb 1993), 244S-248S.
21. B. Giray and F. Hincal, Oxidative DNA base damage, antioxidant enzyme activities and selenium status in highly iodine-deficient goitrous children, Free Radic Res 36 (2002), 55-62.
22. Y. Hasegawa, T. Takano, A. Miyauchi, F. Matsuzuka, H. Yoshida, K. Kuma and N. Amino, Decreased expression of catalase mRNA in thyroid anaplastic carcinoma, Jpn J Clin Oncol 33 (2003), 6-9.
23. M. Hicks, L.S. Wong and R.O. Day, Antioxidant activity of propylthiouracil, Biochem Pharmacol 43 (1992), 439-444.
24. 2 generation is partially inhibited by propylthiouracil and methimazole, Eur J Biochem 270 (2003), 2363-2368.
25. H. Bikker, Dissertation for PhD thesis, University of Amsterdam, 1996.
26. -2, Thyroid 8 (1998), 185-191.
27. J.J.M. De Vijlder and M.T. den Hartog, The reason why the thyroid secretes mainly thyroxine. 11th International Thyroid Congress, Toronto Canada, 1995, S-162.
28. H.E. Seifried, S.S. McDonald, D.E. Anderson, P. Greenwald and J.A. Milner, The antioxidant conundrum in cancer, Cancer Res 63 (2003), 4295-4298.
29. R. Gerschman, D.L. Gilbert, S.W. Nye, P.W. Nadig and W.O. Fenn, Role of adrenalectomy and adrenal cortical hormones in oxygen poisoning, Am J Physiol 179 (1954), 115-118.
30. K. Asayama and K. Kato, Oxidative muscular injury and its relevance to hyperthyroidism, Free Rad Biol Med 8 (1990), 293-303.
31. F. Costantini, S.D. Pierdomenico, D.D. Cesare, P De Remigis, T. Bucciarelli, G. Bittolo-Bon, G. Cazzolato, G. Nubile, M.T. Guagnano, S. Sengi, F. Cuccurullo and A. Mezzetti, Effect of Thyroid Function on LDL Oxidation, Arterioscler Thromb Vasc Biol 18 (1998), 732-737.
32. A. Bonanome, A. Pagnan, S. Biffanti, A. Opportuno, F. Sorgato, M. Dorella, M. Maiorino and F. Ursini, Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification, Arterioscler Thromb 12 (1992), 529-533.
33. A. Dugrillon, Iodolactones and iodoaldehydes-mediators of iodine in thyroid autoregulation, Exp Clin Endocrinol Diabetes 104(4) (1996), 41-45.
34. J. Wolff and I.L. Chaikoff, Plasma inorganic iodide as a homeostatic regulator of thyroid function, J Biol Chem 174 (1948), 555-560.
35. M. Vitale, T. Di Matola, F. D'Ascoli, S. Salzano, F. Bogazzi, G. Fenzi, E. Martino and G. Rossi, Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress, Endocrinology 141 (2000), 598-605.
36. N. Uyttersprot, N. Pelgrims, N. Carrasco, C. Gervy, C. Maenhaut, J.E. Dumont and F. Miot, Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na+/I- symporter mRNA's in dog thyroid, Molecular and Cellular Endocrinology 131 (1997), 195-203.
37. G.A. Bray, Increased sensitivity of the thyroid in iodine-depleted rats to the goitrogenic effects of thyrotropin, J Clin. Invest. 47 (1968), 1640-1647.
38. J.R. Sherwin and W. Tong, Iodide-induced suppression of thyrotropin-stimulated cyclic amp production and iodinating activity in thyroid cells, Biochimica et Biophysica Acta 404 (1975), 30-39.
39. M.A. Pisarev and M.E. Itoiz, Action of KI on stimulated thyroid protein biosynthesis, Endocrinology 90(5) (May 1972), 1409-1412.
40. J.F. Mutaku, J.F. Poma, M.C. Many, J.F. Denef and M.F. van den Hove, Cell necrosis and apoptosis are differentially regulated during goiter development and iodine-induced involution, Journal of Endocrinology 172 (2002), 375-386.
41. B. Contrempre, J.F. Denef, J.E. Dumont and M.C. Many, Selenium deficiency aggravates the necrotizing effects of a high iodide dose in iodine deficient rats, Endocrinology 132 (1993), 1866-1868.
42. M.B. Zimmermann and J. Kohrle, The Impact of Iron and Selenium Deficiencies on Iodine and Thyroid Metabolism: Biochemistry and Relevance to Public Health, Thyroid 12 (2002), 867-878.
43. 2 generated at the apical surface of thyr cells in autocatalytic covalent heme binding, J Biol Chem 274 (1999), 10533-10538.
44. F. Bogazzi, L. Bartalena, M. Gasperi, L.E. Braverman and E. Martino, Various Effects of Amiodarone on Thyroid Function, Thyroid 11 (2001), 511-519.
45. M.C. Many, J. Papadopolos, C. Martin, I. Colin and J.R. Denef, Iodine induced cell damage in mouse hyperplastic thyroid is associated to lipid peroxidation, in: Progress in Thyroid Research, A. Gordon, K. Gross and G. Hennemann, eds, 18 Ilkema, Rotterdam, 1991, pp. 635-636.
46. B. Contrempre, J.E. Dumont and N. Bebe et al., Effect of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine deficient subjects with selenium, J Clin Endocrinol Metab 73 (1991), 213-215.
47. R. Gartner, B.C.H. Gasnier, J.W. Dietrich, B. Krebs and M.W.A. Angstwurm, Selenium Supplementation in Patients with Autoimmune Thyroditis Decreases Thyroid Peroxidase Antibodies Concentrations, J Clin Endo Metab 87 (2002), 1687-1691.
48. L.H. Duntas, E. Mantzou and D.A. Koutras, Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis, European Jour Endo 148 (2003), 389-393.
49. R. Winkler, S. Griebenow and W. Wonisch, Effect of Iodide on Total Antioxidant Status of Human Serum, Cell Bio and Function 18 (2000), 143-146.
50. F. Tatzber, S. Griebenow, W. Wonisch and R. Winkler, Dual method for the determination of peroxide activity and total peroxides-iodide leads to a significant increase of peroxidase activity in human sera, Analytical Biochemistry 316 (2003), 147-153.
51. C. Spitzweg, K.J. Harrington, L.A. Pinke, R.G. Vile and J.C. Morris, The Sodium Symporter and Its Potential Role in Cancer Therapy, J of Clin Endo and Metab 86 (2001), 3327-3335.
52. I.L. Wapnir, M. van de Rijn, K. Nowels, P.S. Amenta, K. Walton, K. Montgomery, R.S. Greco, O. Dohan and N. Carrasco, Immunohistochemical Profile of the Sodium/Iodide Symporter in Thyroid, Breast, and Other Carcinomas Using High Density Tissue Microarrays and Conventional Sections, The Journal of Clin Endo and Metab 88 (2003), 1880-1888.
53. M.T. Kilbane, R.A. Ajjan, A.P. Weetman, R. Dwyer, E.W.M. McDermott, N.J. O'Higgins and P.P.A. Smyth, Tissue Iodine Content and Serum Mediated 1251 Uptake Blocking Activity in Breast Cancer, Journal of Clinical Endocrinology and Endocrinology 85 (2000), 1245-1250.
54. U.K. Tazebay, I.L. Wapnir, O. Levy, O. Dohan, L.S. Zuckier, Q.H. Zhao, H.F. Deng, P.S. Amenta, S. Fineberg, R.G. Pestell and N. Carrasco, The Mammary Gland Iodide Transporter is Expressed During Lactation and in Breast Cancer, Nat Med 6 (2000), 871-878.
55. J.A. Rillema, T.X. Yu and S.M. Jhiang, Effect of prolactin on sodium iodide symporter expression in mouse mammary gland explants, Am J Physiol Endocrinol Metab 279 (2000), E769-772.
56. J.A. Rillema and M.A. Hill, Prolactin regulation of the pendrin-iodide transporter in the mammary gland, Am J Physiol Endocrinol Metab 284 (2003), E25-28. Epub 2002 Sep 11.
57. J.M. Strum, P.C. Phelps and M.M. Mc Atee, Resting human female breast tissue produces iodinated proteins, J Ultrastructure Research 84 (1983), 130-139.
58. N.F. Boyd and V McGuire, The possible role of lipid peroxidation in breast cancer risk, Free Rad Biol Med 10 (1991), 185-190.
59. H.J. Sipe Jr, S.J. Jordan, P.M. Hanna and R.P. Mason, The metabolism of 17 beta-estradiol by lactoperoxidase: a possible source of oxidative stress in breast cancer, Carcinogenesis 11 (1994), 2637-2643.
60. M.A. Trush and T.W. Kensler, An overview of the relationship between oxidative stress and chemical carcinogenesis, Free Rad Biol Med 10 (1991), 201-209.
61. S. Ching, D. Ingram, R. Hahnel, J. Beilby and E. Rossi, Serum Levels of Micronutrients, Antioxidants and Total Antioxidant Status Predict Risk of Breast Cancer in a Case Control Study, J Nutrit 132 (2002), 303-306.
62. M.F. Polat, S. Taysi, M. Gul, O. Cikman, I. Yilmaz, E. Bakan and F. Erdogan, Oxidant/antioxidant status in blood of patients with malignant breast tumour and benign breast disease, Cell Biochemistry and Function 20 (2002), 327-331.
63. S.A. Cann, J.P. van Netten and C. van Netten, Hypothesis: Iodine, selenium and the development of breast cancer, Cancer Causes and Control 11 (2000), 121-127.
64. S. Venturi, Is there a role for iodine in breast diseases? "The Breast" Journal 10 (2001), 379-382.
65. B.A. Eskin, Iodine metabolism and Breast Cancer, Trans NY Acad Sci 11 (1970), 911-947.
66. N.M. Shah, B.A. Eskin, T.B. Krouse and C.E. Sparks, Iodoprotein formation by rat mammary glands during pregnancy and early postpartum period, Proc Soc Exp Biol Med 181 (1986), 443-449.
67. G.M. Bogardus and J.W. Finley, Breast cancer and thyroid disease, Surgery 49 (1961), 461-468.
68. P.P.A. Smyth, D.F. Smith, E.W.M. Mc Dermott, M.J. Murray, J.G. Geraghty and N.J. O'Higgins, A direct relationship between thyroid enlargement and breast cancer, J Clin Endocr Metab 81 (1996), 937-941.
69. W.R. Ghent, B.A. Eskin, D.A. Low and L.P. Hill, Iodine replacement in fibrocystic breast disease, Canadian J Surgery 36 (1993), 453-459.
70. H. Funahashi, T. Imai, Y. Tanaka, J. Tobinaga, M. Wada, T. Morita, F. Yamada, K. Tsukamura, M. Oiwa, T. Kikumori, T. Narita and T. Hiroshi, Suppressive effect of iodine on DMBA-induced breast tumor growth in the rat, J Surg. Oncol. 61 (1996), 209-213.
71. H. Funahashi, Wakame Seaweed Suppresses the Proliferation of 7,12-Dimethylbenz(a)-anthracene-induced Mammary Tumours in Rats, Jpn. J. Cancer Res. 90 (1999), 992-997.
72. H. Funahashi, T. Imai, T. Mase, M. Sekiya, K. Yokoi, H. Hayashi, A. Shibata, T. Hayashi, M. Nishikawa, N. Suda, Y. Hibi, Y. Mizuno, K. Tsukamura, A. Hayakawa and S. Tanuma, Seaweed Prevents Breast Cancer? Jpn. J. Cancer Res 92 (2001), 483-487.
73. P. Pisani, D.M. Parkin, F. Bray and J. Ferlay, Estimates of the worldwide mortality from 25 cancers in 1990, Int J Cancer 83 (1999), 18-29.
74. L. Le Marchand, L.N. Kolonel and A.M. Nomura, Breast cancer survival among Hawaii Japanese and Caucasian women. Ten year rates and survival by place of birth, Am J Epidemiol 122 (1985), 571-578.
75. Y. Minami, A. Takano, Y. Okuno, A. Fukao, M. Kurihara and S. Hisamichi, Trends in the incidence of female breast and cervical cancers in Miyagi Prefecture, Japan, 1959-1987, Jpn J Cancer Res 87 (1996), 10-17.
76. N. Tajima, H. Tsukuma and A. Oshima, Descriptive epidemiology of male breast cancer in Osaka, Japan, J Epidemiol 11 (2001), 1-7.
77. B.A. Eskin, C.E. Grotkowski, C.P. Connolly and W.R. Ghent, Different Tissue Responses for Iodine and Iodide in Rat Thyroid and Mammary Glands, Biological Trace Element Research 49 (1995), 9-19.
78. R.M. Dwyer, M.T. Kilbane, R.A. Ajjan, D.F. Smith, A.P. Weetman, E.W.M. Mc Dermott, N.J. Higgins and P.P.A. Smyth, The Sodium Symporter (NIS), Iodine and Breast Cancer, Endo 164 (2000), P400.
79. M.B. Goldman, Thyroid diseases and breast cancer, Epidemiol Rev 12 (1990), 16-28.
80. P.P.A. Smyth, The Thyroid and Breast Cancer: A Significant Association? Ann Med 29 (1997), 189-191.
81. K. Itoh and N. Maruchi, Breast cancer in patients with Hashimoto's thyroiditis, Lancet ii (1975), 1119-1121.
82. C. Giani, P. Fierabracci, R. Bonacci, A. Gigliotti, D. Campani, F. De Negri, D. Cecchetti, E. Martino and A. Pinchera, Relationship between Breast Cancer and Thyroid Disease: Relevance of Autoimmune Thyroid Disorders in Breast Malignancy, J Clin Endocr Metab 81 (1996), 990-994.
83. P.P.A. Smyth, S.G. Shering, M.T. Kilbane, M.J. Murray and E.W.M. McDermott, Smith DF and O'Higgins N.J. Serum TPO autoantibodies, thyroid volume and outcome in breast carcinoma, Journal of Clinical Endocrinology and Endocrinology 83(1998), 2711-2715.
84. P.P.A. Smyth, Autoimmune Thyroid Disease and Breast Cancer: A Chance Association? Journal of Endocrinological Investigation 23 (2000), 42-43.
85. N.J. Sarlis, L. Gourgiotis, F. Pucino and G.J. Tolis, Lack of association between Hashimoto thyroiditis and breast cancer: A quantitive research synthesis 1(1) (2002), 35-41.
86. A. Franzke, D. Peest, M. Probst-Kepper, J. Buer, G.I. Kirchner, G. Brabant, H. Kirchner, A. Ganser and J. Atzpodien, Autoimmunity Resulting From Cytokine Treatment Predicts Long-Term Survival in Patients With Metastatic Renal Cell Cancer, J Clin Oncol 17 (1999), 529-533.
87. P.P.A. Smyth, C.G. Brennan, D. Kavanagh, D.F. Smith, F. Fleming, E.W.M. McDermott, A.D.K. Hill, N.J. O'Higgins, P. Barrett and C.P. Thompson, Serum TSH and thyroid autoantibodies in thyroidal and extrathyroidal disease, Endocrine Abstracts 5 (2003), P271.